nalidixic acid has been researched along with sulfamethazine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Gleadle, RI; Lawson, DH; Linton, AL | 1 |
| Brown, PC; Donaghy, MC; Dootson, PH; MacLaren, DM; Titcombe, DH | 1 |
| Konícková, L; Prát, V | 1 |
| Gardiner, S; Waite, RD; Wareham, DW; Whiley, RA | 1 |
8 other study(ies) available for nalidixic acid and sulfamethazine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Extended therapy in patients with established urinary tract infection.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Chronic Disease; Escherichia coli; Escherichia coli Infections; Female; Hospitalization; Humans; Male; Middle Aged; Nalidixic Acid; Nitrofurantoin; Pyelonephritis; Sulfamethazine; Urinary Tract Infections; Urine | 1971 |
Sulphadimidine and nalidixic acid therapy in urinary-tract infections in general practice.
Topics: Adolescent; Adult; Drug Resistance, Microbial; Escherichia coli; Family Practice; Female; Humans; Male; Nalidixic Acid; Sulfamethazine; Urinary Tract Infections | 1971 |
[Importance of animal experiments for antibcterial therapy of infection of the urinary tract in man].
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Nalidixic Acid; Nitrofurantoin; Rats; Sulfamethazine; Urinary Tract Infections | 1971 |
A simple, semiselective medium for anaerobic isolation of anginosus group streptococci from patients with chronic lung disease.
Topics: Chronic Disease; Culture Media; Culture Techniques; Humans; Lung Diseases; Nalidixic Acid; Prevalence; Respiratory Tract Infections; Sputum; Streptococcal Infections; Streptococcus anginosus; Sulfamethazine | 2012 |